Search
Descriptor English: Arsenic Trioxide
Descriptor Spanish: Trióxido de Arsénico
Descriptor trióxido de arsénico
Entry term(s) Arsenic(III) Oxide
As2O3
As4O6
Naonobin
Trisenox
Trixenox
anhídrido arsenioso
arsenolita
hexaóxido de tetra-arsénico
hexaóxido de tetraarsénico
trióxido de diarsénico
óxido de arsénico (As2O3)
óxido de arsénico (As4O6)
óxido de tetraarsénico
Scope note: Compuesto inorgánico con la fórmula química As2O3 que se usa para el tratamiento de la LEUCEMIA PROMIELOCÍTICA AGUDA en pacientes que han sufrido una recidiva con el tratamiento farmacológico convencional o que son resistentes a este.
Descriptor Portuguese: Trióxido de Arsênio
Descriptor French: Trioxyde d'arsenic
Entry term(s): Arsenic Oxide (As2O3)
Arsenic Oxide (As4O6)
Arsenic(III) Oxide
Arsenolite
Arsenous Anhydride
As2O3
As4O6
Diarsenic Trioxide
Naonobin
Tetra Arsenic Hexaoxide
Tetra Arsenic Oxide
Tetra-Arsenic Hexaoxide
Tetra-Arsenic Oxide
Tetraarsenic Hexaoxide
Tetraarsenic Oxide
Trisenox
Trixenox
Tree number(s): D01.075.038
D01.650.550.125
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077237
Scope note: An inorganic compound with the chemical formula As2O3 that is used for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA in patients who have relapsed from, or are resistant to, conventional drug therapy.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antineoplastic Agents
Registry Number: S7V92P67HO
Public MeSH Note: 2019; ARSENIC TRIOXIDE was indexed under ARSENICALS and OXIDES 1975-2018
History Note: 2019 (1975)
DeCS ID: 57559
Unique ID: D000077237
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/02/27
Arsenic Trioxide - Preferred
Concept UI M0049263
Scope note An inorganic compound with the chemical formula As2O3 that is used for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA in patients who have relapsed from, or are resistant to, conventional drug therapy.
Preferred term Arsenic Trioxide
Entry term(s) Arsenic Oxide (As2O3)
Arsenic(III) Oxide
Arsenous Anhydride
As2O3
Diarsenic Trioxide
Tetraarsenic Oxide - Narrower
Concept UI M0479370
Scope note A form of As2O3 that exists as As4O6 in the solid state. It dissociates to As2O3 upon heating to the vapor phase above 800 degrees Celsius.
Preferred term Tetraarsenic Oxide
Entry term(s) Arsenic Oxide (As4O6)
Arsenolite
As4O6
Tetra Arsenic Hexaoxide
Tetra Arsenic Oxide
Tetra-Arsenic Hexaoxide
Tetra-Arsenic Oxide
Tetraarsenic Hexaoxide
Naonobin - Narrower
Concept UI M0555701
Preferred term Naonobin
Trisenox - Narrower
Concept UI M0398306
Preferred term Trisenox
Entry term(s) Trixenox



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey